Non-benzodiazepine hypnotic use for sleep disturbance in people aged over 55 years living with dementia: a series of cohort studies

Keyphrases

• People with Dementia 100%
• Sleep Disturbance 100%
• Z-drugs 100%
• Non-benzodiazepine 100%
• Hypnotic Use 100%
• Primary Care 46%
• Clinical Cohort Study 46%
• Fracture Risk 30%
• Drug Use 30%
• Dementia 23%
• Confidence Interval 23%
• Quality of Life 23%
• Nursing Homes 23%
• Dementia with 15%
• Tricyclic Antidepressants 15%
• Carers 15%
• Hazard Ratio 15%
• Health Technology Assessment 15%
• National Institute for Health Research 15%
• Venous Thromboembolism 15%
• National Alzheimer's Coordinating Center 15%
• Dose Effect 7%
• European Union 7%
• Well-being 7%
• Effective Management 7%
• Cognitive Function 7%
• Benzodiazepines 7%
• Antipsychotics 7%
• Randomized Controlled Trial 7%
• Management Strategy 7%
• Resource Use 7%
• Research Journals 7%
• Disease Course 7%
• Primary Care Practice 7%
• Norway 7%
• Cumulative Dose 7%
• Zolpidem 7%
• Insomnia 7%
• Existing Data 7%
• Safe Management 7%
• Neuropsychiatric Symptoms 7%
• Low Quality Data 7%
• Care Homes 7%
• Disability 7%
• Fall-related Fracture 7%
• Hip Fracture 7%
• Excess Risk 7%
• Residual Confounding 7%
• Fall Risk 7%
• Assessment Programs 7%
• Project Information 7%
• Drug Use Initiation 7%
• Primary Care Patients 7%
• Clinical Datasets 7%
• Library Website 7%
• Multiple Outcomes 7%
• Hospitalization Data 7%
• Clinical Practice Research Datalink 7%
• Hospital Episode Statistics 7%
• Electronic Register 7%
• Post-authorisation Studies 7%
• Zaleplon 7%
• Observational Cohort Study 7%
• Office for National Statistics 7%
• Fall Prevention 7%
• Cognitive Qualities 7%
• Zopiclone 7%
• Secondary Exposure 7%
• Mortality Data 7%
• NHS England 7%
• Alzheimer Disease Research Center 7%
• False-positive Findings 7%
• Dementia Severity 7%

Medicine and Dentistry

• Primary Health Care 100%
• Cohort Analysis 100%
• Sleep Disorder 100%
• Nonbenzodiazepine 100%
• Drug Use 50%
• Quality of Life 37%
• Nursing Home 37%
• Infection 25%
• Apoplexy 25%
• Low Drug Dose 25%
• Hazard Ratio 25%
• Venous Thromboembolism 25%
• Tricyclic Antidepressant 25%
• Alzheimer's Disease 12%
• Cognition 12%
• Clinical Study 12%
• Randomized Controlled Trial 12%
• False Positive Result 12%
• Disease Course 12%
• Hip Fracture 12%
• Typical Antipsychotic 12%
• Cohort Study 12%
• Technology Assessment 12%
• Assessment in Health Technology 12%
• Health Technology 12%
• Zolpidem 12%
• Zaleplon 12%
• Zopiclone 12%
• Fall Prevention 12%
• Benzodiazepine Derivative 12%

Nursing and Health Professions

• Sleep Disorder 100%
• Cohort Analysis 100%
• Z-Drug 100%
• Nonbenzodiazepine 100%
• Primary Medical Care 61%
• Drug Use 30%
• Quality of Life 23%
• Confidence Interval 23%
• Nursing Home 23%
• Infection 15%
• Low Drug Dose 15%
• Biomedical Technology Assessment 15%
• Hazard Ratio 15%
• Venous Thromboembolism 15%
• Tricyclic Antidepressant 15%
• Cerebrovascular Accident 15%
• Clinical Practice 7%
• False Positive Result 7%
• Alzheimer's Disease 7%
• Disease Course 7%
• Hip Fracture 7%
• Home Care 7%
• Typical Antipsychotic 7%
• Benzodiazepine Derivative 7%
• Zaleplon 7%
• Zopiclone 7%
• Drug Dose 7%
• Zolpidem 7%